Factor VII Tokushima: the first case of factor VII Cys22Gly with the development of myocardial infarction in the proband receiving recombinant factor VIIa replacement therapy.

Blood Coagul Fibrinolysis

aDepartment of Hematology bDepartment of Cardiovascular Medicine cDepartment of Gastroenterology, Tokushima Prefectural Central Hospital dDepartment of Medicine and Bioregulatory Sciences eDepartment of Medical Education, Graduated School of Health Biosciences, The University of Tokushima, Tokushima, Japan.

Published: December 2015

An 81-year-old man was referred to our department because of suspected factor VII (FVII) deficiency. His FVII activity was under 1%, whereas the FVII activity levels of his son and granddaughter were 65 and 109%, respectively. The nucleotide at position 3886 of his FVII gene was homozygous for G. A single T to G substitution results in the replacement of wild-type Cys at residue 22 by Gly. His son was heterozygous for G and T at position 3886, whereas his granddaughter was homozygous for wild-type T. These results suggest that he was homozygous for FVII Cys22Gly. He underwent radiofrequency ablation (RFA) for hepatocellular carcinoma, receiving 20 μg/kg of recombinant FVIIa prior to RFA and 10 μg/kg of recombinant FVIIa twice after RFA. He showed no bleeding tendency; however, a myocardial infarction was diagnosed and percutaneous coronary intervention was performed.

Download full-text PDF

Source
http://dx.doi.org/10.1097/MBC.0000000000000346DOI Listing

Publication Analysis

Top Keywords

factor vii
12
myocardial infarction
8
fvii activity
8
position 3886
8
recombinant fviia
8
fvii
5
factor
4
vii tokushima
4
tokushima case
4
case factor
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!